Under the slogan "for PhD students, by PhD students", 92 PhD candidates from all over Norway gathered at the historic site of Stiklestad for the first National PhD Conference in Neuroscience. 

Norwegian researchers are involved in developing a new MR imaging technique, vessel architectural imaging (VAI), which offers insights into the treatment of patients with brain tumour. 

The working groups for HelseOmsorg21 ask for input on the future research and innovation strategy for the healthcare sector. The window for providing input opens today and closes on October 14th

Researchers at MIT have successfully implanted false memories in mice by manipulating neurons that are responsible for establishing memory. 

In a new meta-study, Norwegian researchers have looked at how magnetic resonance imaging (MRI) can detect changes in the volumes of different brain structures in Schizophrenia.

Behind the international consensus on EEG interpretation published in Epilepsia this summer, is the system developed and marketed by NNN member company Holberg EEG. 

NNN member Smartfish is a company developing omega-3 based pharmaconutrition products. A study presented at the Alzheimer’s Association International Conference in Boston in July, could potentially link a Smartfish drink to prevention of Alzheimer’s disease. 

NNN are currently working to create an overview of dementia-related medical research and development in Norway. This report will be presented at our national symposium in Oslo.